Clinical trial
Flushing in Social Anxiety Disorder on Cipralex
NCT00485888 · START Clinic for Mood and Anxiety Disorders, Other · Completed
Key facts
| NCT number | NCT00485888 |
|---|---|
| Title | Flushing in Social Anxiety Disorder on Cipralex |
| Official title | Changes in the Vasodilatory Response to Methyl-nicotinate in Response to S-citalopram Treatment in Social Phobia Patients |
| Lead sponsor | START Clinic for Mood and Anxiety Disorders, Other |
| Collaborators | H. Lundbeck A/S Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Social Anxiety Disorder |
| Intervention type | Drug |
| Interventions | Cipralex, Placebo |
| Enrollment | 71 |
| Start date | Oct 1, 2008 |
| Primary completion | Aug 1, 2013 |
| Completion | Aug 1, 2013 |
| First posted | Jun 13, 2007 |
| Last update posted | Oct 30, 2013 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: